Second Genome, Inc. — Form D

Second Genome, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-09. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2011-08-09
• Form: D
• Accession: 0001527224-11-000001
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $5.0M
• Amount sold: $5.0M
• Investors: 12
• Date of first sale: 2011-07-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-164097

Issuer

• Name: Second Genome, Inc.
• CIK: 0001527224
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2009
• Address: 1700 OWENS ST, 5TH FL, SAN FRANCISCO, CA, 94158
• Phone: 888-666-0859

Officers, directors & promoters (7)

More

• CIK 1527224 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search